Depression and Opioid Use Disorder in Woodland Hills

What This Treatment Is

Depression and opioid use disorder co-occur at rates significantly higher than either condition alone would predict. Adults with major depression have elevated rates of OUD, and the reverse holds — active OUD is associated with elevated depression rates, some of which is opioid-induced and some of which predates or persists after the OUD. The combination carries elevated suicide risk, requiring structured clinical vigilance.

The Bidirectional Relationship

Depression can drive opioid use — patients use opioids to blunt emotional pain or manage sleep. Chronic opioid use can produce depression through neurochemical changes affecting reward and mood circuits. Withdrawal states are dysphoric and often meet criteria for depressive episodes. After MAT stabilization, some patients discover an underlying depression that was masked by opioid use, and some find their depression significantly improves.

Buprenorphine’s Mood Effects

There is emerging clinical interest in buprenorphine’s partial κ-opioid antagonism and possible antidepressant effects in some patients. This does not replace targeted depression treatment, but it means the OUD medication itself may have some mood-stabilizing effect for certain patients. Standard care still includes evidence-based depression treatment — SSRI, SNRI, or targeted agents — alongside MAT.

Elevated Healing’s Specialty-Led Approach

Our Woodland Hills program treats co-occurring depression and OUD through coordinated specialty-led tracks. Suicide risk assessment is core to the work — both conditions independently elevate risk, and their combination requires clinical vigilance.

Practically:

• Full psychiatric evaluation for depression severity, subtype, and suicide risk.
• OUD evaluation and MAT medication decision (buprenorphine, naltrexone, or Vivitrol).
• Antidepressant medication when clinically indicated after MAT stabilization.
• Safety planning at intake and at defined intervals — means restriction, warning-sign recognition, acute-response access.
• Evidence-based therapy: CBT for depression, motivational enhancement and CBT-SUD for OUD.
• Coordinated medication review — some antidepressants and MAT medications require careful interaction monitoring.
• Family involvement (with authorization) around safety planning and boundary discussions.

Access at Our Woodland Hills Campus

Our campus is at 21250 Califa St, Ste 114, Woodland Hills, CA 91367, in the West San Fernando Valley. Access is straightforward:

• From the 101 (Ventura Freeway) — exit at De Soto Avenue or Winnetka Avenue and drive a short distance north.
• From the 118 (Ronald Reagan Freeway) — take Winnetka or De Soto south into the West Valley.
• Nearby communities — Warner Center, Winnetka, West Hills, Canoga Park, Tarzana, and Encino are all a short drive.
• Telehealth — after your initial in-person assessment, most follow-up psychiatric visits can be done by video for California residents.

Parking and check-in details are provided at intake. If accessibility accommodations are needed, tell our admissions team when you call.

Program Levels That Deliver This Care

This service is delivered inside the level of care that matches your clinical need at intake. Level of care can shift over time as treatment progresses.

Insurance, Cost, and Getting Started

Most commercial insurance plans cover depression and opioid use disorder under mental health and substance use disorder benefits, which are subject to federal parity requirements under the Mental Health Parity and Addiction Equity Act. Parity means insurers cannot impose stricter limits on behavioral health services than they apply to physical health services — a real legal protection worth knowing you have when you call.

The first step is a conversation with our admissions team. This call is free, confidential, and carries no obligation. During it, we:

• Verify your insurance benefits within one business day.
• Confirm what’s covered, what your copay or coinsurance will be, and whether prior authorization applies.
• Start any required prior authorization on your behalf so you’re not stuck on hold with your insurer.
• Schedule a clinical evaluation — usually within a few business days of your first call, sooner when the situation is time-sensitive.

If insurance doesn’t cover the service or your plan design doesn’t fit, self-pay options can be discussed. There is no charge to have this conversation. Reach us at (747) 888-3000 or use our insurance verification form.

What Progress Looks Like

Recovery through depression and opioid use disorder is not a straight line, and durable clinical outcomes rarely happen in weeks. Realistic timelines matter here more than optimistic promises. Most patients notice measurable improvement in the first month of consistent treatment — reduced cravings, more stable mood, better sleep, easier engagement with therapy. Substantive behavioral change typically takes root over three to six months.

Progress is reviewed at every clinical visit. We measure it in specifics: frequency of the target behavior, functional recovery in work and relationships, sleep quality, and — where medications are involved — how well the pharmacology is holding cravings and side effects. When something isn’t working, we adjust. That might mean a dose change, a therapy focus shift, or a step up or down in level of care. The plan follows the patient’s clinical picture, not the other way around.

Setbacks are treated as clinical data, not moral failure. If a relapse or symptom flare happens, the team’s job is to understand what led to it and refine the plan. Patients are not discharged for a relapse. Long-term recovery is often what happens after the acute treatment phase ends, and we plan for that from the first visit — through aftercare planning, coordinated hand-offs, and telehealth follow-up available across California.

Confidentiality and HIPAA Protections

Treatment records at Elevated Healing are protected under the Health Insurance Portability and Accountability Act (HIPAA) and, for substance use records specifically, under 42 CFR Part 2 — a federal regulation providing additional protection for substance use disorder treatment information. That means treatment status and clinical details are not disclosed to family members, employers, or third parties without your written authorization, except in narrowly defined legal circumstances (imminent harm, court order).

Practical protections include HIPAA-compliant scheduling and communication systems, secure insurance verification channels, and billing structured to minimize what appears on statements. Patients with heightened confidentiality concerns can request specific accommodations at intake — arrival timing, check-in flow, telehealth-first scheduling — and our admissions team will confirm what’s available.

Frequently Asked Questions